시장보고서

상품코드

1481982

유럽의 미생물 동정법 시장 예측(-2030년) : 지역 분석 - 방법, 유형별

Europe Microbial Identification Methods Market Forecast to 2030 - Regional Analysis - By Method and Type

발행일: 2024년 02월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 127 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유럽의 미생물 동정법 시장은 2022년에 12억 3,292만 달러로 평가되며, 2030년에는 21억 5,549만 달러에 달할 것으로 예측되며, 2022-2030년의 CAGR은 7.2%로 성장할 것으로 예측되고 있습니다.

미생물 동정을 촉진하는 정부의 구상과 자금 원조가 유럽의 미생물 동정법 시장을 지원

미생물 식별을 촉진하기 위한 정부의 구상과 자금 지원은 공중보건, 과학 연구 및 산업 발전에 매우 중요한 요소입니다. 이러한 구상은 질병 감시 및 대응 강화부터 미생물학 혁신 연구 지원까지 다양한 목적으로 활용되고 있습니다. 예를 들어 2023년 6월 13일 유럽이사회(EC)는 원헬스 접근법에서 항균제 내성(AMR) 방지를 위한 EU 활동 강화에 대한 권고안을 승인했습니다. 유럽의회는 2023년 6월 1일 AMR 대응을 위한 EU의 행동에 관한 결의안을 통과시켰고, EC는 2023년 4월 26일 의약품 패키지의 일환으로 원헬스 프레임워크에서 항균제 내성 대응을 위한 EU 활동 강화에 관한 이사회 권고안을 채택했습니다. 이사회 권고안을 채택했습니다. 또한 2023년 WHO 유럽 국가들이 AMR 퇴치를 위한 영향력 있는 구상을 식별하고 우선순위를 정하고 실행할 수 있도록 지원하는 새로운 '항균제 내성(AMR)에 관한 유럽 로드맵'이 WHO/유럽 53개 회원국의 보건부 장관 및 대표단의 승인을 받았습니다. 전반적으로 이러한 구상과 자금 조달 메커니즘은 미생물 식별 분야를 지원함으로써 공중 보건을 보호하고 과학적 지식을 발전시키며 경제 성장을 가속하는 데 매우 중요한 역할을 하고 있습니다.

유럽의 미생물 동정법 시장 개요

미생물로 인한 감염성 질환의 확산으로 유럽 전역에서 미생물 동정 검사의 필요성이 증가하고 있습니다. 미생물과 박테리아를 분류하는 것은 더 나은 치료 옵션을 위해 질병을 분석하는 데 매우 중요합니다. 예를 들어 Food Safety News에 따르면 시가스 독소 생성 대장균(STEC)은 2022년 유럽에서 4번째로 많이 발생한 식중독으로 꼽혔습니다. 국가별 신고율이 가장 높은 국가는 아일랜드, 덴마크, 몰타, 가장 낮은 국가는 루마니아, 포르투갈, 그리스, 슬로바키아, 폴란드였습니다. 가장 많은 감염자가 발생한 국가는 독일(1,635명), 덴마크(900명 이상), 아일랜드(900명 미만)가 뒤를 이었습니다. 또한 용혈성요독증후군(HUS)은 거의 모든 연령대에서 362건이 기록되었으며, 0-4세와 5-14세 사이의 젊은 연령층에 환자가 집중되어 있었습니다. 또한 O26, O157, O80, O145가 주요 혈청군으로 나타났습니다. 또한 엘시니어 감염은 2020년 6,800명에서 2019년 ∼6,800명, 5,661명으로 증가하였습니다.

또한 박테리아, 기생충, 곰팡이, 미생물 연구는 제약업계의 많은 투자자들이 의약품 개발 프로젝트에 투자하도록 유도하고 있습니다. 이와는 별도로, 식품의 부패 오염 물질을 식별하기 위한 미생물학적 조사 방법의 필요성은 전 세계에서 식품 안전에 대한 우려가 높아짐에 따라 더욱 커지고 있습니다. 이러한 방법은 가공식품의 진정성과 풍미를 유지하면서 유통기한을 연장할 수 있습니다. 또한 미생물학 및 미생물 식별 장비의 지속적인 발전으로 인해 시장 전망이 긍정적입니다. 예를 들어 2023년 6월 네덜란드에 본사를 둔 인바이옴(inBiome)은 박테리아 감염을 진단하기 위한 PCR 기반의 새로운 분자 플랫폼 출시를 발표했습니다. 이 플랫폼은 시간, 비용, 범위 측면에서 기존 배양이나 시퀀싱과 같은 경쟁사의 새로운 방법을 대체할 수 있다는 것이 회사 측의 설명입니다. 또한 각국 정부는 전염병의 추가 확산을 막기 위해 많은 구상을 취하고 있으며, 의료 산업에 대한 지출 증가와 함께 시장 성장을 가속하고 있습니다.

유럽 미생물 동정법 시장 매출 및 2030년까지의 예측(금액)

유럽 미생물 동정법 시장 세분화

유럽 미생물 동정법 시장은 방법, 유형, 국가별로 구분됩니다.

방법론에 따라 유럽 미생물 동정법 시장은 유전자형, 표현형, 프로테오유형으로 구분되며, 2022년에는 표현형 부문이 가장 큰 점유율을 차지할 것으로 예상됩니다. 유전자형 부문은 다시 기기, 키트, 시약으로 세분화됩니다. 표현형 부문은 기기, 키트, 시약으로 세분화됩니다. 프로테오유형 부문은 기기, 키트, 시약으로 세분화됩니다.

유형별로 유럽 미생물 동정법 시장은 세균 식별 시스템, 미생물 열거 시스템, 내성균 식별 시스템, 미생물학 분석기, 기타로 구분됩니다. 박테리아 식별 시스템 부문이 2022년 가장 큰 점유율을 차지했습니다.

국가별로는 유럽 미생물 동정법 시장은 독일, 프랑스, 이탈리아, 스페인, 영국, 오스트리아, 베네룩스, 기타 유럽으로 구분되며, 2022년 유럽 미생물 동정법 시장은 독일이 독식할 것으로 예상됩니다.

Accelerate Diagnostics Inc, Avantor Inc, Becton Dickinson and Co, bioMerieux SA, Bruker Corp, Danaher Corp, Merck KGaA, Molzym GmbH &Co KG, Shimadzu Corp, Thermo Fisher Scientific Inc는 유럽 미생물 동정법 시장에서 사업을 운영하고 있는 주요 기업입니다.

시장 촉진요인
- 미생물 동정법을 요구하는 식품 안전에 대한 관심의 증가
- 다양한 최종사용자에서 미생물 동정법에 대한 수요의 증가
시장 억제요인
- 자동 미생물 동정 시스템의 고비용
- 복잡한 규제 구조에 의한 신규 미생물 진단 검사의 승인 프로세스의 지연
시장 기회
- 미생물 동정을 촉진하기 위한 정부의 구상과 자금 원조
향후 동향
- 미생물 동정 기술의 진보
영향 분석

제6장 미생물 동정법 시장 : 유럽 시장 분석

유럽의 미생물 동정법 시장 매출, 2020-2030년

제7장 유럽의 미생물 동정법 시장 - 매출과 2030년까지의 예측 : 방법별

시장 매출 점유율, 2022년 및 2030년
유전자형
표현형
Proteotypic

제8장 유럽의 미생물 동정법 시장 - 매출과 2030년까지의 예측 : 유형별

시장 매출 점유율, 2022년 및 2030년
세균 식별 시스템
미생물 동정 시스템
내성균 식별 시스템
미생물 분석기
기타

제9장 유럽의 미생물 동정법 시장 : 국가별 분석

유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 오스트리아
- 베네룩스
- 기타 유럽

제10장 유럽의 미생물 동정법 시장의 업계 상황

유럽의 미생물 동정법 시장의 성장 전략
무기적 성장 전략
유기적 성장 전략

제11장 기업 개요

Avantor Inc
Becton Dickinson and Co
Danaher Corp
bioMerieux SA
Merck KGaA
Thermo Fisher Scientific Inc
Bruker Corp
Shimadzu Corp
Accelerate Diagnostics Inc
Molzym GmbH & Co KG
Biolog Inc

제12장 부록

KSA 24.05.31

The Europe microbial identification methods market was valued at US$ 1,232.92 million in 2022 and is expected to reach US$ 2,155.49 million by 2030; it is estimated to grow at a CAGR of 7.2% from 2022 to 2030.

Government Initiatives and Funding to Promote Microbial Identification Fuel the Europe Microbial Identification Methods Market

Government initiatives and funding promoting microbial identification are crucial pillars of public health, scientific research, and industrial development. These initiatives serve a wide range of purposes, from enhancing disease surveillance and response to supporting innovative research in microbiology. For instance, the Recommendation on intensifying EU activities to prevent Antimicrobial Resistance (AMR) in a One Health approach was accepted by the European Council (EC) on June 13, 2023. The European Parliament passed a resolution on EU action to address AMR on June 1, 2023. The EC adopted a proposal on April 26, 2023, as part of the pharmaceutical package, for a Council Recommendation on stepping up EU activities to address antimicrobial resistance in a One Health framework, together with a Commission Staff Working Document. Further, in 2023, the new European Roadmap on Antimicrobial Resistance (AMR), which assists nations in the WHO European Region in identifying, prioritizing, and putting into practice high-impact initiatives to combat AMR, has received the authorization of health ministers and delegates from WHO/Europe's 53 Member States. Overall, these initiatives and funding mechanisms play a pivotal role in safeguarding public health, advancing scientific knowledge, and driving economic growth by underpinning the microbial identification field.

Europe Microbial Identification Methods Market Overview

The growing prevalence of infectious diseases caused by microorganisms increases the need for microbial identification tests across Europe. Classifying microorganisms and bacteria is crucial for analyzing diseases for better treatment options. For instance, according to Food Safety News, Shiga toxin-producing E. coli (STEC) ranked as the fourth most prevalent foodborne illness in Europe in 2022. Ireland, Denmark, and Malta had the greatest country-specific notification rates, while Romania, Portugal, Greece, Slovakia, and Poland had the lowest rates. The country with the most infections was Germany (1,635), followed by Denmark (over 900) and Ireland (just under 900). In addition, 362 hemolytic uremic syndrome (HUS) cases were documented across practically all age categories, with the youngest age groups-0 to 4 and 5 to 14 years old-having the largest patient concentration. Furthermore, O26, O157, O80, and O145 were the major serogroups. Additionally, Yersinia infections climbed from 6,800 in 2020 to ~6,800 5,661 in 2019.

In addition, studying bacteria, parasites, fungi, and microbes is encouraging many investors in the pharmaceutical industry to invest in drug development projects. Aside from this, the necessity for microbiological identification methodologies to identify food spoilage contaminants is driven by the rising food safety concerns worldwide. These methods increase the shelf life of processed food goods while maintaining their authenticity and flavor. Furthermore, continuous advancements in microbiology and microbial identification equipment create a positive market outlook. For instance, in June 2023, inBiome, the Netherlands-based company, announced the launch of a new PCR-based molecular platform for diagnosing bacterial infections. The company claims the platform can be used in place of conventional culture and rivals' newer methods, such as sequencing, in terms of time, cost, and scope. Moreover, governments of various countries took many initiatives to prevent any further spread of infectious diseases, coupled with the growing expenditure on the healthcare industry, which is propelling the market growth.

Europe Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Million)

Europe Microbial Identification Methods Market Segmentation

The Europe microbial identification methods market is segmented based on method, type, and country.

Based on method, the Europe microbial identification methods market is segmented into genotypic, phenotypic, and proteotypic. The phenotypic segment held the largest share in 2022. The genotypic segment is further subsegmented into instruments, kits, reagents. The phenotypic segment is further subsegmented into instruments, kits, reagents. The proteotypic segment is further subsegmented into instruments, kits, reagents.

By type, the Europe microbial identification methods market is segmented into bacterial identification system, microbial enumeration system, bacterial resistance identification systems, microbiology analyzer, and others. The bacterial identification system segment held the largest share in 2022.

Based on country, the Europe microbial identification methods market is segmented into Germany, France, Italy, Spain, the UK, Austria, Benelux, and the Rest Europe. Germany dominated the Europe microbial identification methods market in 2022.

Accelerate Diagnostics Inc, Avantor Inc, Becton Dickinson and Co, bioMerieux SA, Bruker Corp, Danaher Corp, Merck KGaA, Molzym GmbH & Co KG, Shimadzu Corp, Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe microbial identification methods market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Microbial Identification Methods Market Landscape

4.1 Overview
4.2 Europe PEST Analysis

5. Europe Microbial Identification Methods Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Food Safety Concerns Demanding for Microbial Identification Procedure
- 5.1.2 Rising Demand for Microbial Identification Methods Across Various End Users
5.2 Market Restraints
- 5.2.1 High Cost of Automated Microbial Identification Systems
- 5.2.2 Delay in Approval Process of New Microbial Diagnostic Test Due to Complex Regulatory Framework
5.3 Market Opportunities
- 5.3.1 Government Initiatives and Funding to Promote Microbial Identification
5.4 Future Trends
- 5.4.1 Advancements in Microbial Identification Techniques
5.5 Impact Analysis:

6. Microbial Identification Methods Market - Europe Market Analysis

6.1 Europe Microbial Identification Methods Market Revenue (US$ Mn), 2020 - 2030

7. Europe Microbial Identification Methods Market - Revenue and Forecast to 2030 - by Method

7.1 Overview
7.2 Europe Microbial Identification Methods Market Revenue Share, by Method 2022 & 2030 (%)
7.3 Genotypic
- 7.3.1 Overview
- 7.3.2 Genotypic: Europe Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Europe Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
  - 7.3.2.2 Europe Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
7.4 Phenotypic
- 7.4.1 Overview
- 7.4.2 Phenotypic: Europe Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 Europe Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
  - 7.4.2.2 Europe Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
7.5 Proteotypic
- 7.5.1 Overview
- 7.5.2 Proteotypic: Europe Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.5.2.1 Europe Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
  - 7.5.2.2 Europe Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)

8. Europe Microbial Identification Methods Market - Revenue and Forecast to 2030 - by Type

8.1 Overview
8.2 Europe Microbial Identification Methods Market Revenue Share, by Type 2022 & 2030 (%)
8.3 Bacterial Identification Systems
- 8.3.1 Overview
- 8.3.2 Bacterial Identification Systems: Europe Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Microbial Enumeration Systems
- 8.4.1 Overview
- 8.4.2 Microbial Enumeration System: Europe Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bacterial Resistance Identification Systems
- 8.5.1 Overview
- 8.5.2 Bacterial Resistance Identification Systems: Europe Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Microbiology Analyzers
- 8.6.1 Overview
- 8.6.2 Microbiology Analyzer: Europe Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Europe Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Microbial Identification Methods Market - Country Analysis

9.1 Europe
- 9.1.1 Europe Microbial Identification Methods Market by Country
  - 9.1.1.1 Germany
    - 9.1.1.1.1 Germany: Europe Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.1.2 Germany: Europe Microbial Identification Methods Market, by Method
    - 9.1.1.1.2.1 Germany: Europe Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.1.2.2 Germany: Europe Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.1.2.3 Germany: Europe Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.1.2.4 Germany: Europe Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.1.2.5 Germany: Europe Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.1.2.6 Germany: Europe Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.1.3 Germany: Europe Microbial Identification Methods Market, by Type
  - 9.1.1.2 UK
    - 9.1.1.2.1 UK: Europe Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.2.2 UK: Europe Microbial Identification Methods Market, by Method
    - 9.1.1.2.2.1 UK: Europe Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.2.2.2 UK: Europe Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.2.2.3 UK: Europe Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.2.2.4 UK: Europe Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.2.2.5 UK: Europe Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.2.2.6 UK: Europe Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.2.3 UK: Europe Microbial Identification Methods Market, by Type
  - 9.1.1.3 France
    - 9.1.1.3.1 France: Europe Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.3.2 France: Europe Microbial Identification Methods Market, by Method
    - 9.1.1.3.2.1 France: Europe Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.3.2.2 France: Europe Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.3.2.3 France: Europe Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.3.2.4 France: Europe Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.3.2.5 France: Europe Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.3.2.6 France: Europe Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.3.3 France: Europe Microbial Identification Methods Market, by Type
  - 9.1.1.4 Italy
    - 9.1.1.4.1 Italy: Europe Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.4.2 Italy: Europe Microbial Identification Methods Market, by Method
    - 9.1.1.4.2.1 Italy: Europe Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.4.2.2 Italy: Europe Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.4.2.3 Italy: Europe Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.4.2.4 Italy: Europe Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.4.2.5 Italy: Europe Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.4.2.6 Italy: Europe Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.4.3 Italy: Europe Microbial Identification Methods Market, by Type
  - 9.1.1.5 Spain
    - 9.1.1.5.1 Spain: Europe Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.5.2 Spain: Europe Microbial Identification Methods Market, by Method
    - 9.1.1.5.2.1 Spain: Europe Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.5.2.2 Spain: Europe Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.5.2.3 Spain: Europe Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.5.2.4 Spain: Europe Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.5.2.5 Spain: Europe Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.5.2.6 Spain: Europe Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.5.3 Spain: Europe Microbial Identification Methods Market, by Type
  - 9.1.1.6 Austria
    - 9.1.1.6.1 Austria: Europe Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.6.2 Austria: Europe Microbial Identification Methods Market, by Method
    - 9.1.1.6.2.1 Austria: Europe Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.6.2.2 Austria: Europe Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.6.2.3 Austria: Europe Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.6.2.4 Austria: Europe Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.6.2.5 Austria: Europe Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.6.2.6 Austria: Europe Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.6.3 Austria: Europe Microbial Identification Methods Market, by Type
  - 9.1.1.7 Benelux
    - 9.1.1.7.1 Benelux: Europe Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.7.2 Benelux: Europe Microbial Identification Methods Market, by Method
    - 9.1.1.7.2.1 Benelux: Europe Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.7.2.2 Benelux: Europe Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.7.2.3 Benelux: Europe Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.7.2.4 Benelux: Europe Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.7.2.5 Benelux: Europe Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.7.2.6 Benelux: Europe Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.7.3 Benelux: Europe Microbial Identification Methods Market, by Type
  - 9.1.1.8 Rest of Europe
    - 9.1.1.8.1 Rest of Europe: Europe Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.8.2 Rest of Europe: Europe Microbial Identification Methods Market, by Method
    - 9.1.1.8.2.1 Rest of Europe: Europe Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.8.2.2 Rest of Europe: Europe Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.8.2.3 Rest of Europe: Europe Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.8.2.4 Rest of Europe: Europe Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.8.2.5 Rest of Europe: Europe Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
    - 9.1.1.8.2.6 Rest of Europe: Europe Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
    - 9.1.1.8.3 Rest of Europe: Europe Microbial Identification Methods Market, by Type

10. Europe Microbial Identification Methods Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Europe Microbial Identification Methods Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Avantor Inc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Becton Dickinson and Co
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Danaher Corp
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 bioMerieux SA
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Merck KGaA
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Thermo Fisher Scientific Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Bruker Corp
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Shimadzu Corp
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Accelerate Diagnostics Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Molzym GmbH & Co KG
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
11.11 Biolog Inc
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms